Acumen Pharmaceuticals | 10-Q:2024财年三季报
Acumen Pharmaceuticals | 8-K:Acumen Pharmicals公布2024年第三季度财务业绩和业务亮点
Acumen Pharmaceuticals | 4:持股变动声明-高管 Schacterle Amy
Acumen Pharmaceuticals | 3:首次持股声明-高管 Schacterle Amy
Acumen Pharmaceuticals | 10-Q:2024财年二季报
Acumen Pharmaceuticals | 8-K:Acumen Pharmicals公布2024年第二季度财务业绩和业务亮点
Acumen Pharmaceuticals | 4:持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
Acumen Pharmaceuticals | 4:持股变动声明-董事 Ives Jeffrey L.
Acumen Pharmaceuticals | 4:持股变动声明-董事 Stoppel Laura
Acumen Pharmaceuticals | 4:持股变动声明-董事 Porter Derrell
Acumen Pharmaceuticals | 4:持股变动声明-董事 Stalfort John A III
Acumen Pharmaceuticals | 4:持股变动声明-董事 Drapkin Kimberlee C
Acumen Pharmaceuticals | 4:持股变动声明-董事 Fountain Nathan B
Acumen Pharmaceuticals | 8-K:重大事件
Acumen Pharmaceuticals | 10-Q:2024财年一季报
Acumen Pharmaceuticals | 8-K:Acumen Pharmicals公布2024年第一季度财务业绩和业务亮点
Acumen Pharmaceuticals | EFFECT:其他
Acumen Pharmaceuticals | ARS:年度报告
Acumen Pharmaceuticals | DEFA14A:其他
Acumen Pharmaceuticals | DEF 14A:股东委托书决议
暂无数据